Interferon-α in corticosteroid-resistant asthma and Churg-Strauss syndrome

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 12, 2003, Pages 1244-1246

  Mouthon, L ^a   Guillevin, L ^a  

^a Université Paris V ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 10; PREDNISONE;

ASTHMA; BLOOD CELL COUNT; CARDIOTOXICITY; CELL DIFFERENTIATION; CHURG STRAUSS SYNDROME; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; EDITORIAL; EOSINOPHIL; FLU LIKE SYNDROME; HEADACHE; HUMAN; LEUKOCYTE COUNT; LOW DRUG DOSE; LUNG FUNCTION TEST; MENTAL DISEASE; MONONUCLEAR CELL; NAUSEA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SIDE EFFECT; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHURG-STRAUSS SYNDROME; DRUG RESISTANCE; HUMANS; INTERFERON-ALPHA;

EID: 0344393720     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1398-9995.2003.00347.x     Document Type: Editorial

References (18)

1. WILLS-KARP M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255-281.
2. UMETSU DT, DEKRUYFF RH. TH1 and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997;100:1-6.
3. WILLS-KARP M, LUYIMBAZI J, XU X, SCHOFIELD B, NEBEN TY, KARP CL et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282: 2258-2261.
4. LI XM, CHOPRA RK, CHOU TY, SCHOFIELD BH, WILLS-KARP M, HUANG SK. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 1996;157:3216-3219.
5. HANSEN G, MCINTIRE JJ, YEUNG VP, BERRY G, THORBECKE GJ, CHEN L et al. CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000; 105:61-70.
6. SUISSA S, ERNST P, BENAYOUN S, BALTZAN M, CAI B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-336.
7. GROSS WL. Churg-Strauss syndrome: update on recent developments. Curr Opin Rheumatol 2002;14:11-14.
8. GUILLEVIN L, COHEN P, GAYRAUD M, LHOTE F, JARROUSSE B, CASASSUS P. Churg-Strauss syndrome: Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:26-37.
9. WECHSLER ME, PAUWELS R, DRAZEN JM. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal? Drug Saf 1999;21:241-251.
10. FLAMM SL. Chronic hepatitis C virus infection. JAMA 2003;289:2413-2417.
11. DRUKER BJ, SAWYERS CL, CAPDEVILLE R, FORD JM, BACCARANI M, GOLDMAN JM. Chronic myelogenous leukemia. Hematology (Am Soc Hematol Educ Program) 2001;87-112.
12. LEVINGS MK, SANGREGORIO R, GALBIATI F, SQUADRONE S, WAAL MALEFYT R, RONCAROLO MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001;166:5530-5539.
13. SIMON H-U, SEELBACH H, EHMANN R, SCHMITZ M. Clinical and immunological effects of low-dose IFN-α treatment in patients with corticosteroid- resistant asthma. Allergy 2003;58:1250-1255.
14. TATSIS E, SCHNABEL A, GROSS WL. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998;129:370-374.
15. KRUIT WH, PUNT KJ, GOEY SH, DE MULDER PH, VAN HOOGENHUYZE DC, HENZEN-LOGMANS SC et al. Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication. Cancer 1994;74:2850-2856.
16. GORDON AC, EDGAR JD, FINCH RG. Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. J Infect 1998;36:229-230.
17. ZUBER M, GAUSE A. Peripheral neuropathy during interferon-alpha therapy in patients with cryoglobulinemia and hepatitis virus infection. J Rheumatol 1997;24:2488-2489.
18. SAITO H, MORITA Y, FUJIMOTO M, NARAZAKI M, NAKA T, KISHIMOTO T. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma. J Immunol 2000;164:5833-5843.